Evaluation of Circulating Tumor Cells-DNA Methylated Separation Nano-Polylactic-co-Glycolic Acid Magnetic Beads with Epithelial Cell Adhesion Molecul/Epidermal Growth Factor Receptor Double Antibody Modification and Its Application in Lung Cancer Diagnosis
Authors:
- 1 December 2021
- journal article
- research article
- Published by American Scientific Publishers in Science of Advanced Materials
- Vol. 13 (12) , 2302-2312
Abstract
Through the dynamic detection of peripheral blood circulating tumor cells (CTCs) and the correlation analysis of DNA methylation, the application of relevant indicators of peripheral blood circulating tumor cells (CTCs) in patients with early lung cancer (LC). Double antibody (EpCAM and EGFR antibodies) modified nano-PLGA magnetic beads have been used for CTC sorting. Functional characterization and analysis were performed to confirm that the prepared nano-PLGA MB had good stability and specificity. Furthermore, the separation and identification of CTCs from lung cancer patients were realized by double-antibody nano-PLGA MB (Ep+ER nano-PLGA MB), suggesting that the system had high separation efficiency, with a positive rate of separation of >80%. Meanwhile, methylation-specific PCR was conducted following the extraction DNA from peripheral blood to analyze the methylation level of p16, MGMT and RASSF1A. Corresponding results revealed that the level of p16 methylation could be used as an important index for lung cancer screening. In addition, the association between CTC-DNA methylation and early screening of tumor was analyzed by integrating the clinical information and related indexes of patients. To sum up, in the screening and identification of lung cancer patients, auxiliary effect can be provided through dynamic monitoring of CTC count in peripheral blood and analysis of CTC-DNA methylation level. It is expected to provide scientific basis for screening, therapeutic strategy formulation, gene correlation analysis and prognosis monitoring of LC.Keywords
This publication has 24 references indexed in Scilit:
- Lung Cancer in Women: Differences in Epidemiology, Biology, Histology, and Treatment OutcomesSeminars in Respiratory and Critical Care Medicine, 2013
- Biostatistics Primer: What a Clinician Ought to Know—Prognostic and Predictive FactorsJournal of Thoracic Oncology, 2013
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human agingAging Cell, 2009
- RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in ChinaJournal of Cancer Research and Clinical Oncology, 2009
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort studyThe Lancet Oncology, 2008
- Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening IssuesCA: A Cancer Journal for Clinicians, 2008
- Gender differences in non-small cell lung cancer: A population-based studyEuropean Journal of Surgical Oncology, 2007
- Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or PleuraClinical Cancer Research, 2006